In agreement with this outcome, we observed reduced METTL3 and METTL14 expression in the majority of postmortem cortex samples from ALS patients (Supplementary Fig. 1c), as well as reduced protein levels as examined by Li et al.36. Here, METTL3 is linked to amyotrophic lateral sclerosis.